Fragmin and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Fragmin (dalteparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Symbicort, and have High blood pressure.

The phase IV clinical study analyzes which people have Visual impairment when taking Fragmin. It is created by eHealthMe based on reports of 11,893 people who have side effects when taking Fragmin from the FDA, and is updated regularly.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.

What is Visual impairment?

Visual impairment is found to be associated with 2,249 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

11,893 people reported to have side effects when taking Fragmin.
Among them, 53 people (0.45%) have Visual impairment.

Among these 53 people:

How long have people been on Fragmin when they have Visual impairment? *

What is the gender of people who have Visual impairment when taking Fragmin? *

female: 50 %
male: 50 %

What is the age of people who have Visual impairment when taking Fragmin? *

What are other drugs people take besides Fragmin? *

What are other side effects people have besides Visual impairment? *

Fatigue (feeling of tiredness): 23 people, 43.40%
Headache (pain in head): 21 people, 39.62%
Weight Decreased: 16 people, 30.19%
Fever: 16 people, 30.19%
Weakness: 14 people, 26.42%
Dyspnea (difficult or laboured breathing): 13 people, 24.53%
Overdose: 11 people, 20.75%
Dehydration (dryness resulting from the removal of water): 11 people, 20.75%
Memory Loss: 11 people, 20.75%
Diarrhea: 10 people, 18.87%

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 18.87%
Pneumonia: 7 people, 13.21%
Age-Related Macular Degeneration: 4 people, 7.55%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 4 people, 7.55%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 7.55%
Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 3 people, 5.66%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.66%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.66%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 3.77%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 3.77%

* Approximation only. Some reports may have incomplete information.

Do you take Fragmin and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fragmin:

Fragmin (11,999 reports)

Visual impairment treatments and more:

Visual impairment (128,338 reports)

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Visual impairment (2,249 drugs)

Browse all the conditions that are associated with Visual impairment:

Visual impairment (2,336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dalteparin sodium (the active ingredients of Fragmin) and Fragmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.